{"company": {"org_id": "Q11F374D12", "org_name_cn": "迪哲(江苏)医药股份有限公司", "org_short_name_cn": "迪哲医药", "org_name_en": "Dizal (Jiangsu) Pharmaceutical Co., Ltd.", "org_short_name_en": "Dizal Pharmaceutical", "main_operation_business": "恶性肿瘤、免疫性疾病领域创新疗法的研究、开发和商业化。", "operating_scope": "　　化学药品制剂、化学药品原料药、生物药品的研发、批发；技术开发、技术转让、技术服务；自营和代理各类商品及技术的进出口业务（国家限定企业经营或禁止进出口的商品和技术除外）；经济与商务咨询（不含投资咨询）。（依法须经批准的项目，经相关部门批准后方可展开经营活动）许可项目：药品生产；药品批发；药品零售（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以审批结果为准）", "district_encode": "320214", "org_cn_introduction": "迪哲(江苏)医药股份有限公司的主营业务是恶性肿瘤、免疫性疾病领域创新疗法的研究、开发和商业化。公司的主要产品是舒沃哲、高瑞哲、Birelentinib、DZD6008。", "legal_representative": "张小林", "general_manager": "张小林", "secretary": "吕洪斌", "established_date": 1509033600000, "reg_asset": 459412894.0, "staff_num": 852, "telephone": "86-21-61095757", "postcode": "214135;201203", "fax": "86-21-58387361", "email": "ir@dizalpharma.com", "org_website": "www.dizalpharma.com", "reg_address_cn": "江苏省无锡市新吴区和风路26号汇融商务广场C栋404、405、416室", "reg_address_en": null, "office_address_cn": "江苏省无锡市新吴区和风路26号汇融商务广场C栋404、405、416室;上海市浦东新区中国(上海)自由贸易试验区亮景路199、245号4幢", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1639065600000, "provincial_name": "江苏省", "actual_controller": "", "classi_name": "其他", "pre_name_cn": null, "chairman": "张小林", "executives_nums": 15, "actual_issue_vol": 40000100.0, "issue_price": 52.58, "actual_rc_net_amt": 1986567800.0, "pe_after_issuing": null, "online_success_rate_of_issue": 0.03039654, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}}